NY-738

N/A

Report date: 2026/04/22 20:01:10

Base Information

Drug NameNY-738
Drug Alias NameNY-738
ClassificationRadiation-emitting products > Nuclides > Astatine > 211AtRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionLymphocyte differentiation antigen CD38 modulators
TargetsLymphocyte differentiation antigen CD38
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNAYA Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNAYA Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A